Company Fennec Pharmaceuticals Inc Other OTC
Equities
CA31447P1009
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sodium Thiosulfate
100.0
%
| 2 | 100.0 % | 29 | 100.0 % | +1,335.37% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 29 | 100.0 % | +1,335.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 14-04-24 |
Mark Gowland
AUD | Comptroller/Controller/Auditor | 52 | 15-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 11-08-24 |
Khalid Islam
CHM | Chairman | 67 | 14-04-24 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 14-04-24 |
Marco Brughera
BRD | Director/Board Member | 70 | 16-08-09 |
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Jodi Cook
BRD | Director/Board Member | 56 | 19-09-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,099,908 | 22,954,258 ( 84.70 %) | 0 | 84.70 % |
Company contact information
Fennec Pharmaceuticals, Inc.
Research Triangle Park 68 T.W. Alexander Drive
27709, Durham
+919 636 4530
http://www.fennecpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |